Characterization of human multicentric osteosarcoma using newly established cells derived from multicentric osteosarcoma

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 3, 2011, Pages 423-433

  Yamamoto, Y ^a   Yamamoto, N ^b   Tajima, K ^a   Ohno, A ^a   Washimi, Y ^a   Ishimura, D ^a   Washimi, O ^a   Yamada, H ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

DNA microarray; Human multicentric osteosarcoma cell; Invasiveness of extracellular matrix; Telomerase activity; Telomere length

Indexed keywords

COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; TELOMERASE; VASCULOTROPIN;

ARTICLE; CANCER INVASION; CANCER TISSUE; CELL ASSAY; CELL STRAIN; CHROMOSOME SIZE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTICENTRIC OSTEOSARCOMA; OSTEOSARCOMA; OSTEOSARCOMA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; TELOMERE;

ADOLESCENT; BONE NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OSTEOSARCOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 79954451284     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0885-9     Document Type: Article

References (38)

1. Amstutz HC (1969) Multiple osteogenic sarcoma-metastatic or multicentric? Report of two cases and review of literature. Cancer 24:923-931
2. Biagini R, Ruggieri P, De Cristofaro R, Torricelli P, Picci P, Bacci G (1991) Multicentric osteosarcoma. Report of 5 cases. Chir Organ Mov 76:113-122
3. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271-1274. doi:10.1038/nm1197-1271 (Pubitemid 27508830)
4. Cho HJ, Lee TS, Park JB, Park KK, Choe JY, Sin DI et al (2007) Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol 40:1069-1076
5. Clark JC, Dass CR, Choong PF (2008) A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol 134:281-297. doi:10.1007/s00432-007-0330-x (Pubitemid 351170066)
6. Daffner RH, Kennedy SL, Fox KR, Crowley JJ, Sauser DD, Cooperstein la (1997) Synchronous multicentric osteosarcoma: the case for metastasis. Skel Radiol 26:569-578. doi:10.1007/s002560050289 (Pubitemid 27472471)
7. de Lange T (2002) Protection of mammalian telomeres. Oncogene 21:532-549. doi:10.1038/sj/onc/1205080 (Pubitemid 34146253)
8. Foukas AF, Deshmukh NS, Grimer RJ, Mangham DC, Mangos EG, Taylor S (2002) Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells. J Bone Joint Surg Br 84:706-711. doi:10.1302/0301-620X.84B5.12512
9. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA (1999) Creationofhuman tumour cells with defined genetic elements. Nature 400:464-468. doi:10.1038/22780 (Pubitemid 29361801)
10. Hatori M, Ohtani H, Yamada N, Uzuki M, Kokubun S (2001) Synchronous multifocal osteosarcoma with lymphatic spread in the lung: an autopsy case report. Jpn J Clin Oncol 31:562-566 (Pubitemid 33138243)
11. Henson JD, Neumann AA, Yeager TR, Reddel RR (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene 21:598-610. doi:10.1038/sj/onc/1205058 (Pubitemid 34146260)
12. Hojilla CV, Mohammed FF, Khokha R (2003) Matrixmetalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89:1817-1821. doi:10.1038/sj.bjc.6601327 (Pubitemid 37533251)
13. Hue HL, Quan K, Jong KP, Weike S, Qing L, Wei J et al (2005) An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metast 22:319-329. doi: 10.1007/s10585-005-0365-9 (Pubitemid 41374288)
14. Jaffe N, Pearson P, Yasko AW, Lin P, Herzog C, Raymond K (2003) Single and multiple metachronous osteosarcoma tumors after therapy. Cancer 98:2457-2466. doi:10.1002/cncr.11800 (Pubitemid 37466661)
15. Jones RD, Reid R, Balakrishnan G, Barret A (1993) Multifocal synchronous osteosarcoma: the Scottish bone tumour registry experience. Med Pediatr Oncol 21:111-116 (Pubitemid 23029854)
16. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015. doi:10.1126/science. 7605428
17. Kyo S, Masutomi K, Maida Y, Kanaya T, Yatabe N, Nakamura M, Tanaka M, Takarada M, Sugawara I, Murakami S, Taira T, Inoue M (2003) Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase. Am J Pathol 163:859-867 (Pubitemid 37040122)
18. Laus M (1980) Multicentric osteosarcoma. Ital Orthop Traumatol 6:249-254 (Pubitemid 11135432)
19. Lisle JW, Choi JY, Horton JA, Allen MJ, Damron TA (2008) Metastatic osteosarcoma gene expression differs in vitro and in vivo. Clin Orthop Relat Res 466:2071-2080. doi:10.1007/s11999-008-0309-1
20. Lockshin MD, Higgins ITT (1966) Bone metastasis in osteogenic sarcoma. Arch Intern Med 118:203-204
21. Lowbeer L (1968) Multifocal osteosarcomatosis; a rare entity. Bull Pathol 9:52-53
22. Mahoney JP, Spanier SS, Morris JL (1979) Multifocal osteosarcoma: a case report with review of the literature. Cancer 44:1897-1907 (Pubitemid 10141972)
23. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795. doi:10.1016/S0092-8674 (00) 80538-3 (Pubitemid 27357969)
24. Mirra JM (1989) Multifocal osteosarcoma. In: Mirra JM (ed) Bone tumors: clinical, radiologic and pathologic correlations. Lea & Febiger, Philadelphia, PA, pp 344-350
25. Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG (2007) Prognostic significance of vascular endothelial cell growth factors-A,-C and-D in breast cancer and their relationship with angio-and lymphangiogenesis. Br J Cancer 96:1092-1100. doi:10.1038/sj.bjc.6603678 (Pubitemid 46608319)
26. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959. doi:10.1126/science.277.5328.955 (Pubitemid 27366681)
27. Oda Y, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Yokoyama R, Iwamoto Y, Tsuneyoshi M (2006) CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol 19:738-745. doi: 10.1038/modpathol.3800587
28. Parham DM, Pratt CB, Parvey LS, Webber BL, Champion J (1985) Childhood multifocal osteosarcoma. Clinicopathologic and radiologic correlates. Cancer 55:2653-2658 (Pubitemid 15092154)
29. Sato H, Takino T, Miyamori H (2005) Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis. Cancer Sci 96:212-217. doi:10.1111/j.1349-7006.2005.00039.x (Pubitemid 40767057)
30. Scheel C, Poremba C (2002) Telomere lengthening in telomerasenegative cells: the ends are coming together. Virchows Arch 440:573-582. doi:10.1007/s00428-002-0634-9 (Pubitemid 34809687)
31. Scheel C, Schaefer KL, Jauch A, Keller M, Wai D, Brinkschmidt C et al (2001) Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20:3835-3844 (Pubitemid 32646194)
32. Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791. doi:10.1016/S0959-8049 (97) 00062-2
33. Terasaki T, Kyo S, Takakura M, Maida Y, Tsuchiya H, Tomita K, Inoue M (2004) Analysis of telomerase activity and telomere length in bone and soft tissue tumors. Oncol Rep 11:1307-1311
34. Uchibori M, Nishida Y, Nagasaka T, Yamada Y, Nakanishi K, Ishiguro N (2006) Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol 28:33-42
35. Ulaner GA, Huang HY, Otero J, Zhao Z, Leah BP, Satagopan JM (2003) Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res 63:1759-1763 (Pubitemid 36469314)
36. Virk MS, Lieberman JR (2007) Tumor metastasis to bone. Arthritis Res Ther 9 (Suppl 1): S5. doi:10.1186/ar2169 (Pubitemid 351803971)
37. Weiss KR, Cooper GM, Jadlowiec JA, McGough RL 3rd, Huard J (2006) VEGF and BMP expression in mouse osteosarcoma cells. Clin Orthop Relat Res 450:111-117. doi:10.1097/01.blo. 0000229333.98781.56 (Pubitemid 44342124)
38. Yamamoto Y, Yamamoto N, Tajima K, Ohno A, Washimi Y, Ishimura D, Washimi O, Yamada Y (2008) Establishment of two cell lines derived from synchronous type of human multicentric osteosarcoma (HMOS) and the expression of the chemokine CXCR4/CXCL12 axis in this condition. Tiss Cult Res Common 27:161-168 (Japanese)